phone icon Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

Metabolomics Market Expected to Reach $3,301 Million by 2023

report_img

quote Metabolomics is an innovative approach for the treatment and diagnosis of chronic diseases. Increased adoption of metabolomics in drug development and personalized healthcare is expected to fuel the market growth during the forecast period.quote


Sriram Radhakrishnan, Team Lead, Healthcare at AMR



Need More Information?

Talk to Rahul Thakur

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

call   Toll Free : +1-800-792-5285

call   UK : + 44-845-528-1300

call   Hong Kong : + 852-301-84916

call   India (Pune) : +91 20 66346060

call   Fax : +1⟨855⟩550-5975

mail  help@alliedmarketresearch.com

 

According to a new report published by Allied Market Research, titled, Metabolomics Market by Product & Service, Application, and Indication: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global metabolomics market accounted for $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. North America was the highest contributor to the global metabolomics market in 2016; while, Asia-Pacific is anticipated to witness the highest growth rate throughout the forecast period.

Access Full Summary at: https://www.alliedmarketresearch.com/metabolomics-market

Metabolomics uses various analytical methods, such as spectroscopy, chromatography, and multivariate analysis, for the identification & quantification of various metabolites. The analytical methods facilitate the classification of various known & unknown metabolites in the reaction. The comprehensive nature of metabolites enables its application in diverse medical fields; thereby, facilitating the development of new therapeutic procedures and diagnostics tests.

The global metabolomics market is expected to grow at a lucrative rate during the forecast period due to increased adoption of metabolomics in precision medicine and surge in R&D investments. Moreover, technological advancements in auxiliary medical devices used for metabolomics analysis and growth in demand for the development of quality medications are expected to fuel the metabolomics market. However, high cost of medical devices and lack of effective data management for metabolomic profiling hamper the market growth.

The biomarker discovery segment accounted for the highest market share in 2016, and is expected to continue this trend during the forecast period. Technological advancements in quantification methods & technologies and increase in concerns related to prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, are expected to drive the growth of this segment.

Key Findings of the Metabolomics Market:

  • The drug discovery segment is estimated to grow at the highest rate during the forecast period.
  • The biomarker discovery segment generated the highest revenue in 2016, and is expected to continue its dominance in the near future.
  • North America dominated the global market in 2016.
  • China is expected to grow at the highest CAGR in the Asia-Pacific region.

North America accounted for the highest market share in 2016, owing to surge in R&D investment and availability of modern healthcare facilities. Moreover, increased use of experimental medicines and growth in adoption of metabolomics in precision medicine are expected to boost the North America metabolomics market. However, Asia-pacific is expected to grow at the highest CAGR during the forecast period due to rapid adoption of metabolomics in medical research, increase in disposable income, and surge in government initiatives to discover cost-effective treatments for chronic diseases.

The key companies profiled in the report include Agilent Technologies, Inc., Danaher Corporation, Biocrates Life Sciences AG, Bruker Corporation, Leco Corporation, Metabolon, Inc., Human Metabolome Technologies, Inc., Bio-Rad Laboratories, Inc., Shimadzu Corporation, Waters Corporation, and Thermo Fisher Scientific Inc.


First time buyer?   Click here..                                         
To get this report  
 
 

Why Allied Market Research?

 

Inflallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

 

Further Readings

rep-img

Nov 2017

Collision Avoidance System Market

Read More >
rep-img

Nov 2017

SaaS-based SCM Market

Read More >
rep-img

Nov 2017

Cephalosporin Market

Read More >
rep-img

Nov 2017

Spoolable Pipes Market

Read More >
 

Get fresh content delivered weekly

Get insights on topics that matter to your business. Stay updated on the areas that interest you.